HRP20100549T1 - Makrolidi s protuupalnom aktivnošću - Google Patents

Makrolidi s protuupalnom aktivnošću Download PDF

Info

Publication number
HRP20100549T1
HRP20100549T1 HR20100549T HRP20100549T HRP20100549T1 HR P20100549 T1 HRP20100549 T1 HR P20100549T1 HR 20100549 T HR20100549 T HR 20100549T HR P20100549 T HRP20100549 T HR P20100549T HR P20100549 T1 HRP20100549 T1 HR P20100549T1
Authority
HR
Croatia
Prior art keywords
alkyl
compound
formula
unsubstituted
substituted
Prior art date
Application number
HR20100549T
Other languages
English (en)
Croatian (hr)
Inventor
Culic Ognjen
Bosnar Martina
Marjanovic Nikola
Jelic Dubravko
Alihodzic Sulejman
Vela Vanja
Marusic-Istuk Zorica
Erakovic Vesna
Bo�njak Berislav
Hrvacic Boska
Tomaskovic Marija
Munic Vesna
Ivetic Vanesa
Hutinec Antun
Kragol Goran
Leljak Marija
Original Assignee
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. filed Critical GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o.
Publication of HRP20100549T1 publication Critical patent/HRP20100549T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20100549T 2005-01-13 2006-01-13 Makrolidi s protuupalnom aktivnošću HRP20100549T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64384105P 2005-01-13 2005-01-13
US71582805P 2005-09-09 2005-09-09
PCT/IB2006/001238 WO2006087644A2 (en) 2005-01-13 2006-01-13 Macrolides with anti-inflammatory activity

Publications (1)

Publication Number Publication Date
HRP20100549T1 true HRP20100549T1 (hr) 2010-11-30

Family

ID=36916830

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100549T HRP20100549T1 (hr) 2005-01-13 2006-01-13 Makrolidi s protuupalnom aktivnošću

Country Status (18)

Country Link
US (2) US8080529B2 (enExample)
EP (1) EP1851236B1 (enExample)
JP (1) JP5036558B2 (enExample)
KR (1) KR20070105993A (enExample)
CN (1) CN101142225B (enExample)
AT (1) ATE476438T1 (enExample)
AU (1) AU2006215315B2 (enExample)
CA (1) CA2594820A1 (enExample)
CY (1) CY1110866T1 (enExample)
DE (1) DE602006015919D1 (enExample)
DK (1) DK1851236T3 (enExample)
HR (1) HRP20100549T1 (enExample)
IL (1) IL184438A (enExample)
NO (1) NO20074162L (enExample)
PL (1) PL1851236T3 (enExample)
PT (1) PT1851236E (enExample)
RS (1) RS51479B (enExample)
WO (1) WO2006087644A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011518799A (ja) * 2008-04-23 2011-06-30 グラクソ グループ リミテッド ２’−ｏ，３’−ｎ−橋かけマクロライド
CN101423539B (zh) * 2008-12-09 2011-04-27 山东大学 4″,11-二氨基甲酸酯阿奇霉素衍生物、制备方法及其药物组合物
JP5437394B2 (ja) * 2009-01-30 2014-03-12 グラクソ グループ リミテッド 抗炎症性マクロライド
WO2011018510A1 (en) 2009-08-13 2011-02-17 Basilea Pharmaceutica Ag New macrolides and their use
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
EP4095146A1 (en) 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
EP2984087A1 (en) 2013-04-10 2016-02-17 Probiotic Pharmaceuticals APS Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
JP2017531663A (ja) * 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ １４員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
GB201520419D0 (en) 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds
US12390440B2 (en) * 2020-03-12 2025-08-19 Zoetis Services Llc Immunomodulating trifluoromethyl-aminal azalides
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)
CN114858953B (zh) * 2022-05-20 2023-11-21 大连工业大学 一种动物源食品中红霉素及降解产物的检测试剂盒及检测方法
GB202404587D0 (en) 2024-03-28 2024-05-15 Epiendo Pharmaceuticals Ehf Chemical forms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (en) * 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
HRP980189B1 (en) 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
CN100577681C (zh) * 2002-07-08 2010-01-06 葛兰素伊斯特拉齐瓦基森塔萨格勒布公司 用于治疗炎性疾病和病症的新化合物、组合物和方法
GB0310986D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
ES2317527T3 (es) 2005-01-13 2009-04-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Decladinosil-macrolidos que presentan actividad anti-inflamatoria.
EP1836212B1 (en) 2005-01-14 2011-09-07 Glaxo Group Limited Macrolide compounds containing biotin and photo-affinity group for macrolide target identification
JP5437394B2 (ja) 2009-01-30 2014-03-12 グラクソ グループ リミテッド 抗炎症性マクロライド

Also Published As

Publication number Publication date
US8080529B2 (en) 2011-12-20
WO2006087644A3 (en) 2007-03-15
PL1851236T3 (pl) 2011-05-31
DE602006015919D1 (de) 2010-09-16
CY1110866T1 (el) 2015-06-10
JP2008526950A (ja) 2008-07-24
JP5036558B2 (ja) 2012-09-26
DK1851236T3 (da) 2010-11-22
IL184438A0 (en) 2008-12-29
CN101142225B (zh) 2011-09-07
CN101142225A (zh) 2008-03-12
EP1851236B1 (en) 2010-08-04
WO2006087644A2 (en) 2006-08-24
RS51479B (sr) 2011-04-30
AU2006215315A1 (en) 2006-08-24
US20120058963A1 (en) 2012-03-08
HK1112920A1 (en) 2008-09-19
CA2594820A1 (en) 2006-08-24
NO20074162L (no) 2007-09-18
KR20070105993A (ko) 2007-10-31
EP1851236A2 (en) 2007-11-07
ATE476438T1 (de) 2010-08-15
PT1851236E (pt) 2010-10-25
IL184438A (en) 2011-12-29
US20080221046A1 (en) 2008-09-11
AU2006215315B2 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
ES2779225T3 (es) Reactivos de merilformilo sustituido y procedimiento de uso de los mismos para modificar propiedades fisicoquímicas y/o farmacocinéticas de compuestos
JP2005519932A5 (enExample)
DE60313472T2 (de) Pyrrolidindion-substituierte piperidin-phthalazone als pde4-inhibitoren
SK14912000A3 (sk) Imidazopyridínové deriváty, ktoré inhibujú vylučovanie žalúdočnej kyseliny, spôsob ich prípravy, medziprodukty tohto spôsobu a farmaceutická formulácia
RU2018113451A (ru) Гетероарильные соединения в качестве ингибиторов irak и их применение
RU2002127682A (ru) Замещенные бета-карболины
RU2010119645A (ru) Замещенные гетероциклом пиперазинодигидротиенопиримидины
RU2012110882A (ru) Производные 6-аминохиназолина или 3-цианохинолина, способы их получения и их фармацевтические применения
JP2004535447A5 (enExample)
JP2005524621A5 (enExample)
ME00876B (me) 4"supstituisani-9-deokso-9a-aza-9a-homoeritromicin a derivati
EP4045037A1 (en) Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases
JP2005505618A5 (enExample)
JP2005511532A5 (enExample)
JP2015501820A5 (enExample)
RU98102128A (ru) Производные бензо[g]хинолина
NO20062905L (no) Nye hydroksaminsyreestere og farmasoytisk anvendelse derav
JP2011507896A5 (enExample)
KR20090110834A (ko) 대사 증후군을 치료하기 위한 치환된 피라논산 유도체의 용도
JP2013522241A (ja) アゴメラチン塩酸塩水和物およびその製造
JP2005530730A5 (enExample)
JP2008526950A5 (enExample)
JP2006517218A5 (enExample)
RU2008151761A (ru) Производные имидазоазепинона
ES2348360T3 (es) Derivados de bencimidazol: preparación y aplicaciones farmacéuticas.